Procurement Summary
Country: Brazil
Summary: Purchase of Medicine(S) Belonging to Group 0936 (Registered Medicines for Specific Purchase), in Order to Comply with Court Orders to the Detriment of the State Department of Health of The...
Deadline: 15 May 2026
Posting Date: 04 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140630408
Document Ref. No.: 90140/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Purchase of medicine(s) belonging to Group 0936 (REGISTERED MEDICINES FOR SPECIFIC PURCHASE), in order to comply with court orders to the detriment of the State Department of Health of the Federal District - SES/DF, in price registration system, according to specifications and quantities contained in Annex I of the Notice. UASG code: 926119 Notice from: 05/04/2026 from 08:00 to 12:00 and from 13:00 to 17:00 Proposal Delivery: from 05/04/2026 at 08:00 DICLOFENAC, COMPOSITION DIETHYLAMONIUM SALT, CONCENTRATION 20 MG/G, PHARMACEUTICAL GEL FORM Quantity: 36 ECULIZUMAB, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 324 ECULIZUMAB, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 108 MEMANTINE, COMPOSITION SALT HYDROHYDRATE, CONCENTRATION 10 MG Quantity: 1080 METHYLFENIDATE HYCLORIDATE, DOSAGE 36 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE Quantity: 1080 NITISINONE, CONCENTRATION 2 MG Quantity: 1080 MEDICINAL EXTRACT, ACTIVE INGREDIENT DRY EXTRACT OF SENNA ALEXANDRINA, COMPOSITION ASSOCIATED WITH CASSIA FISTULA, CONCENTRATION 4, 878 MG/G + 4, 719 MG/G, PHARMACEUTICAL FORM JELLY Quantity: 36 SEVELAMER, ACTIVE INGREDIENT CHLORHYDRATE, DOSAGE 800 MG Quantity : 4320 TETRAHYDROCANABINOL, DELTA-9-THC TYPE, COMPOSITION ASSOCIATED WITH CANNABIDIOL (CBD), CONCENTRATION 27 MG/ML + 25 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION - DROPS Quantity: 108 VANDETANIB, CONCENTRATION 300 MG Quantity: 2160 VENLAFAXINE, SALT COMPOSITION HYDROHOLDRATE, CONCENTRATION 75 MG, CONTROLLED RELEASE PRESENTATION Quantity: 8640
Documents
Tender Notice